Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Maxigesic IV postoperative pain relief safety study
ACTRN12619000587101Phase 3Completed
- Sponsor
- AFT Pharmaceuticals
- Start
- Jul 2019
- Modality
- Small Molecules
- Countries
- 2
01
Overview
Phase 3, open-label, single-arm trial of Combogesic IV, acetaminophen and ibuprofen in postoperative pain, sponsored by AFT Pharmaceuticals. Primary endpoint: Incidence of treatment-emergent adverse events. Started Jul 2019; status: completed.
02
Drugs
Combogesic IVacetaminophenibuprofen
03
Conditions
postoperative pain
Beyond the preview
Go deeper on ACTRN12619000587101.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12619000587101.